JSP191 for MDS/AML
Trial Summary
What is the purpose of this trial?
This trial tests JSP191, an antibody that helps clear out diseased blood cells, in adults with MDS or AML who are getting a stem cell transplant. By blocking a critical connection on blood cells, JSP191 makes room for new, healthy stem cells.
Research Team
Lori Muffly, MD,MS
Principal Investigator
Stanford University
Andrew Artz, MD,MS
Principal Investigator
City of Hope Medical Center
Bart Scott, MD
Principal Investigator
Fred Hutchinson Cancer Center
Catherine Lee, MD
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Arpita Gandhi, MD
Principal Investigator
Oregon Health and Science University
Ankur Varma, MD,PhD
Principal Investigator
Rush University Medical Center
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- JSP191 (Monoclonal Antibody)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jasper Therapeutics, Inc.
Lead Sponsor